Robotic Transplant an Option for Obese Kidney Patients
The findings should allow more obese patients to receive kidney transplants.
Patients with a body mass index (BMI) greater than 35 who have end-stage kidney disease are often denied transplantation, and patients with a BMI over 40 often die on dialysis without an opportunity for transplant. Obesity "markedly increases the risk of wound infection, which lowers graft and patient survival," said Dr. Jose Oberholzer, chief of transplantation surgery at University of Illinois Hospital and lead author of the study, in the March issue of the American Journal of Transplantation.
Minimally invasive robotic transplantation may reduce health disparities for obese patients with end-stage kidney disease, according to the study authors.
Up to half of dialysis patients are obese, defined as having a body mass index greater than 30. Studies have shown that obese patients with chronic kidney failure wait longer for transplants and consequently have poorer outcomes than non-obese patients. However, obese transplant patients who don't have surgical site infections have similar kidney transplant success rates as non-obese patients.
Obese patients often have diabetes and hypertension as a result of being overweight. Seventy percent of hypertensive dialysis patients and 75 percent of diabetic dialysis patients survive less than five years, previous research has shown.
University of Illinois Hospital surgeons have developed a new robotic technique that avoids any incision in the infection-prone lower abdomen and uses only a small incision above the belly-button.
Physicians identified 28 obese patients who received robotic kidney transplants at UI Hospital between June 2009 and December 2011. They followed the patients for six months after transplant and compared their outcomes with a group of 28 obese patients who received traditional "open" kidney transplantation at the hospital prior to 2009.
There were no surgical site infections in the robotic patients, while 29 percent of patients in the control group developed an infection. Measurements of kidney function, graft and patient survival were comparable in the two groups.
Source: University of Illinois Hospital & Health Sciences System
Published on : Tue, 21 May 2013
Print as PDF
The iLA Membrane Ventilator is an extrapulmonary ventilation system which is used primarily to remove carbon dioxide. The heart pumps blood through it as it does through a natural organ. The gas exchange takes place via a plasma-tight, heparin-coated...
FeaturesMindray BeneVision Central Monitoring System is a powerful and scalable solution providing for continuous, real-time surveillance across networks large and small. The system can display patient information from networked monitors, wireless transport...
The Accelerate PhenoTest™ BC kit is the first application of the Accelerate Pheno™ system. It provides with less 5 minutes operator hands-on time within 1.5 hour the identification of the most prevalent micro-organisms seen in blood stream infections....
Q-NRG is the first Indirect Calorimeter specifically intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing and for healthy subjects.Q-NRG is a unique product, resulting...
The fully-automated Accelerate Pheno™ system is designed to eliminate the lengthy culture and sample preparation steps required for most sample types prior to antimicrobial susceptibility testing. In addition, it hosts proprietary molecular identification...